Senecioylcholine in Heterometrus spinifer scorpion venom activates vertebrate nicotinic acetylcholine receptors

Posted by
  Senecioylcholine in Heterometrus spinifer scorpion venom activates vertebrate nicotinic acetylcholine receptors Abstract Introduction: Scorpion venoms are natural sources of neurotoxins that primarily modulate the properties of neuronal ion channels, particularly voltage-gated sodium and potassium channels. However, they also contain a variety of small bioactive molecules that have been largely neglected in the omics era of toxinological research. Methods: In the present study, we employed a high-throughput FLIPR screen of arthropod venoms against nicotinic acetylcholine receptors (nAChRs) expressed in the human SH-SY5Y neuroblastoma cell line. Results: The venom of the Malaysian forest scorpion Heterometrus spinifer (family: Scorpionidae) proved to be an agonist of nAChRs, and the small choline ester senecioylcholine was identified as being responsible for the observed effect. Synthetic senecioylcholine and its isomers tigloylcholine and angeloylcholine were not insecticidal wh...

Deadly cures: Unlocking anticancer potential of reptile, amphibian, and arthropod venoms through molecular innovation and nanotechnology

Posted by

 


Deadly cures: Unlocking anticancer potential of reptile, amphibian, and arthropod venoms through molecular innovation and nanotechnology

Abstract

Venoms from reptiles, amphibians, and arthropods represent a rich source of bioactive molecules with promising anticancer potential. Recent studies have highlighted the selective cytotoxicity of venom components including snake phospholipase A2 enzymes, scorpion peptides (chlorotoxin), and frog derived antimicrobial peptides against cancer cells. These molecules exert multifaceted effects, such as inducing apoptosis, inhibiting metastasis, and modulating the tumor microenvironment, thereby impairing tumor growth and progression. Advances in nanotechnology based delivery systems and peptide engineering have significantly improved the stability, bioavailability, and specificity of venom derived agents, enhancing their safety and therapeutic efficacy. Preclinical investigations demonstrate potent anticancer activity across multiple tumor models, and early clinical studies suggest translational potential. Current research continues to explore the molecular mechanisms underlying venom-mediated cytotoxicity, while formulation strategies and regulatory considerations are being optimized to facilitate clinical development. Future directions include the design of synthetic venom analogs, AI assisted drug discovery, and personalized medicine approaches, which collectively aim to harness the full therapeutic potential of venom peptides. By integrating natural bioactivity with modern biomedical technologies, venom derived compounds are emerging as a novel and promising avenue in the development of next-generation oncological therapeutics. This review provides a comprehensive overview of venom diversity, anticancer mechanisms, recent advances in formulation and delivery, and the challenges and opportunities for translating venom-based agents into clinical practice.
Shankar, P. R., & Unni, A. (2026). Deadly cures: Unlocking anticancer potential of reptile, amphibian, and arthropod venoms through molecular innovation and nanotechnology. Next Nanotechnology, 9, 100378. https://doi.org/10.1016/j.nxnano.2026.100378